Evidence map›Paper›PMID 35369090›Full record

ReviewFrontiers in nutrition2022

Resveratrol in Intestinal Health and Disease: Focusing on Intestinal Barrier.

Youxia Wang, Changming Hong, Zebiao Wu, Shuwei Li, Yaoyao Xia, Yuying Liang, Xiaohua He, Xinyu Xiao, Wenjie Tang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Youxia WangCollege of Animal Science, South China Agricultural University, Guangzhou, China.
Changming HongCollege of Animal Science, South China Agricultural University, Guangzhou, China.
Zebiao WuCollege of Animal Science, South China Agricultural University, Guangzhou, China.
Shuwei LiAnimal Breeding and Genetics Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China.
Yaoyao XiaCollege of Animal Science, South China Agricultural University, Guangzhou, China.
Yuying LiangCollege of Animal Science, South China Agricultural University, Guangzhou, China.
Xiaohua HeCollege of Animal Science, South China Agricultural University, Guangzhou, China.
Xinyu XiaoCollege of Animal Science, South China Agricultural University, Guangzhou, China.
Wenjie TangAnimal Breeding and Genetics Key Laboratory of Sichuan Province, Sichuan Animal Science Academy, Chengdu, China.
South China Agricultural University · CNSichuan Animal Science Academy · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The integrity of intestinal barrier determines intestinal homeostasis, which could be affected by various factors, like physical, chemical, and biological stimuli. Therefore, it is of considerable interest and importance to maintain intestinal barrier function. Fortunately, many plant polyphenols, including resveratrol, could affect the health of intestinal barrier. Resveratrol has many biological functions, such as antioxidant, anti-inflammation, anti-tumor, and anti-cardiovascular diseases. Accumulating studies have shown that resveratrol affects intestinal tight junction, microbial composition, and inflammation. In this review, we summarize the effects of resveratrol on intestinal barriers as well as the potential mechanisms (e.g., inhibiting the growth of pathogenic bacteria and fungi, regulating the expression of tight junction proteins, and increasing anti-inflammatory T cells while reducing pro-inflammatory T cells), and highlight the applications of resveratrol in ameliorating various intestinal diseases.

Indexed as

anti-inflammationantioxidantanti-tumorintestinal barrierresveratrol

Identifiers

PMID35369090
PMCPMC8966610
OpenAlexW4221092826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.